These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8735716)

  • 1. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
    Minato H; Nakanuma Y; Terada T
    Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
    Terada T; Nakanuma Y
    Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
    Lee KT; Liu TS
    Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
    Terada T; Nakanuma Y; Sirica AE
    Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of expression of carbohydrate chain structures during human intrahepatic bile duct development and maturation: a lectin-histochemical and immunohistochemical study.
    Terada T; Nakanuma Y
    Hepatology; 1994 Aug; 20(2):388-97. PubMed ID: 8045500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
    Haas S; Gütgemann I; Wolff M; Fischer HP
    Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
    Tang X; Zhang J; Chen Y; Lan Z; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.
    Feng YJ; Zhang BY; Yao RY; Lu Y
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):418-23. PubMed ID: 22893470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.
    Lee KT; Sheen PC
    J Surg Oncol; 1995 Jun; 59(2):131-5. PubMed ID: 7776654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.